AR093204A1 - Composicion estabilizante para materiales biologicos y metodo de produccion - Google Patents

Composicion estabilizante para materiales biologicos y metodo de produccion

Info

Publication number
AR093204A1
AR093204A1 ARP130100968A ARP130100968A AR093204A1 AR 093204 A1 AR093204 A1 AR 093204A1 AR P130100968 A ARP130100968 A AR P130100968A AR P130100968 A ARP130100968 A AR P130100968A AR 093204 A1 AR093204 A1 AR 093204A1
Authority
AR
Argentina
Prior art keywords
food
composition
consumption
human
composition according
Prior art date
Application number
ARP130100968A
Other languages
English (en)
Inventor
Harel Moti
Tang Qiong
Carpenter Brian
Drewes Roger
Scarbrough January
Rice Trisha
jennings Kimberly
Reditsis Elizabeth
Original Assignee
Advanced Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionutrition Corp filed Critical Advanced Bionutrition Corp
Publication of AR093204A1 publication Critical patent/AR093204A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/30Puffing or expanding
    • A23P30/32Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Reivindicación 1: Una composición estabilizadora seca para un material bioactivo, que comprende un componente carbohidrato que comprende entre aproximadamente 10% y 80% de oligosacáridos, entre aproximadamente 5% y 30% de disacáridos y entre aproximadamente 1% y 10% de polisacáridos; y un componente proteína que comprende entre aproximadamente 0,5% y 40% de proteínas hidrolizadas de animales o plantas; referido al peso total de la composición. Reivindicación 9: La composición de acuerdo con cualquier reivindicación, en donde la composición está combinada con el material bioactivo. Reivindicación 19: Un líquido reconstituido, un polvo molido, un comprimido, una pella, una cápsula, un alimento para consumo humano o animal o producto semilla recubierta, que comprende la composición de acuerdo con la reivindicación 9. Reivindicación 21: Un alimento para consumo humano, un aditivo para los alimentos de consumo humano, un alimento para consumo animal, un para alimentos de consumo animal, un producto nutracéutico, farmacéutico, agrícola o vacuna, en la forma de una barra, fórmula líquida, suspensión coloidal, polvo, comprimido, cápsula y semilla recubierta, que comprende la composición de acuerdo con el reivindicación 9.
ARP130100968A 2012-03-23 2013-03-25 Composicion estabilizante para materiales biologicos y metodo de produccion AR093204A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614994P 2012-03-23 2012-03-23
US201261642094P 2012-05-03 2012-05-03
US201261646337P 2012-05-13 2012-05-13

Publications (1)

Publication Number Publication Date
AR093204A1 true AR093204A1 (es) 2015-05-27

Family

ID=49223367

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100968A AR093204A1 (es) 2012-03-23 2013-03-25 Composicion estabilizante para materiales biologicos y metodo de produccion

Country Status (17)

Country Link
EP (1) EP2827905A4 (es)
JP (1) JP6229188B2 (es)
KR (1) KR102062645B1 (es)
CN (2) CN114601849A (es)
AR (1) AR093204A1 (es)
AU (1) AU2013234931B2 (es)
BR (1) BR112014023234B1 (es)
CA (1) CA2866889C (es)
CL (1) CL2014002506A1 (es)
IN (1) IN2014DN08599A (es)
MX (1) MX356072B (es)
MY (1) MY178686A (es)
NZ (1) NZ628912A (es)
PH (1) PH12014502092A1 (es)
RU (1) RU2666601C2 (es)
SG (1) SG11201405478VA (es)
WO (1) WO2013142792A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255583A1 (en) * 2013-03-06 2014-09-11 Sunny Delight Beverages Company Protein suspension as a beverage opacifier system
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
BR112017017147B1 (pt) * 2015-02-11 2024-02-20 Prevtec Microbia Inc Processo para fornecimento de escherichia coli (e. coli) viável embebida em uma matriz na forma de uma partícula
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US10792313B2 (en) * 2015-12-04 2020-10-06 Advanced Bionutrition Corp. Stable dry compositions having no or little sugars
FR3045384B1 (fr) 2015-12-18 2020-02-07 Institut National De La Recherche Agronomique Composition lyophilisee pour la conservation de microbiote dans son ecosysteme
EP3389396B1 (en) * 2015-12-18 2019-11-13 Société des Produits Nestlé S.A. Hydration for animals
CN105504050A (zh) * 2016-03-03 2016-04-20 河南欧普生物科技有限公司 一种抗安卡拉病毒鸡卵黄抗体的制备方法
CN108884434B (zh) 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
CN117898368A (zh) * 2016-06-14 2024-04-19 Evah 营养公司 包含饲料添加剂的动物饲料颗粒、其制备和使用方法
WO2017219106A1 (pt) 2016-06-24 2017-12-28 Yessinergy Holding S/A Composição imunomoduladora e promotora de crescimento e de controle da população de bactérias indesejáveis da microbiota intestinal e seu uso
KR101766430B1 (ko) 2016-10-28 2017-08-08 주식회사 삼양사 올리고당을 함유하는 알룰로오스 시럽 및 그 제조방법
CN106819418A (zh) * 2017-03-27 2017-06-13 张军军 一种超高脂饲料及其制备方法
US10323226B2 (en) * 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
CN113614055B (zh) * 2018-12-07 2023-12-26 皮沃特生物股份有限公司 用于固氮微生物产品的具有提高的稳定性的聚合物组合物
WO2020130770A1 (es) * 2018-12-19 2020-06-25 Ajtzakbio S.A.P.I. De C.V. Composición probiótica de alto valor sin necesidad de cadena de frio, desarrollada para reducir el impacto ambiental, aumentar la producción y mejorar la supervivencia de larvas de camarón
WO2021055352A1 (en) * 2019-09-16 2021-03-25 Vedanta Biosciences, Inc. Methods and compositions for preserving bacteria
JP2022553401A (ja) * 2019-10-22 2022-12-22 マサチューセッツ インスチテュート オブ テクノロジー 植物成長促進微生物を送達するための生体材料ベースの組成物
CN110923145B (zh) * 2019-12-16 2021-07-20 天康制药(苏州)有限公司 支原体的冻干保护剂与冻干支原体及其制备方法
US11576937B2 (en) 2020-02-06 2023-02-14 Nch Corporation Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition
US20230080017A1 (en) * 2020-02-19 2023-03-16 Zantebio Limited Coated microcapsules and methods for the production thereof
RU2746022C1 (ru) * 2020-04-03 2021-04-06 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Способ стабилизации бактериальных клеток чумного микроба перед сублимационным высушиванием
RU2736064C1 (ru) * 2020-04-03 2020-11-11 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Защитная среда для стабилизации клеток возбудителя туляремии в процессе приготовления и хранения сухих препаратов
EP4252541A1 (en) * 2020-12-25 2023-10-04 Hayashibara Co., Ltd. Method for improving productivity in livestock and/or poultry and method for improving intestinal flora in livestock and/or poultry
WO2022171617A1 (en) * 2021-02-10 2022-08-18 Dsm Ip Assets B.V. Powderous composition (i)
JP2024506466A (ja) * 2021-02-10 2024-02-14 ディーエスエム アイピー アセッツ ビー.ブイ. 粉末状組成物(ii)
CN112843328B (zh) * 2021-02-25 2022-05-13 山东大学 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法
CN113621519B (zh) * 2021-08-11 2023-07-18 河南农业大学 一种复合酵母冻干保护剂
CN114196579A (zh) * 2021-12-13 2022-03-18 张峰 一种建筑通风工程用的甲醛微生物净化器
WO2023204734A1 (ru) * 2022-04-21 2023-10-26 Общество С Ограниченной Ответственностью "Кинетик-Фарм" Средство для интравагинальной доставки активного компонента, способ получения и применения средства
CN117247305A (zh) * 2023-09-16 2023-12-19 鲁东大学 一种促进植物根系生长的水凝胶及制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1212045T (pt) * 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
EP1296656B1 (en) 2000-06-27 2006-08-02 F. Hoffmann-La Roche Ag Method for preparing a composition
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
JP4902103B2 (ja) * 2002-04-11 2012-03-21 メディミューン・エルエルシー 凍結乾燥フォームによる生物活性材料の保存
AU2003265010A1 (en) * 2002-09-16 2004-04-30 Quest International Services B.V. Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
ES2470340T3 (es) * 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
CA2673120C (en) * 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
AU2008343689A1 (en) * 2007-12-20 2009-07-09 Abbott Laboratories Stable nutritional powder
RU2521642C2 (ru) * 2008-10-20 2014-07-10 Нестек С.А. Питательная композиция с противосрыгивающими свойствами
TWI468157B (zh) * 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法,進行該方法的系統及包含該錠劑的包裝物
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
CN103140145B (zh) * 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物

Also Published As

Publication number Publication date
BR112014023234A2 (pt) 2017-06-20
JP2015517985A (ja) 2015-06-25
MY178686A (en) 2020-10-20
CA2866889A1 (en) 2013-09-26
BR112014023234A8 (pt) 2018-01-16
CL2014002506A1 (es) 2015-01-09
CA2866889C (en) 2021-08-31
PH12014502092B1 (en) 2014-11-24
EP2827905A1 (en) 2015-01-28
BR112014023234B1 (pt) 2020-12-08
KR20140135845A (ko) 2014-11-26
NZ628912A (en) 2016-06-24
CN114601849A (zh) 2022-06-10
RU2014136089A (ru) 2016-05-20
WO2013142792A1 (en) 2013-09-26
SG11201405478VA (en) 2014-11-27
EP2827905A4 (en) 2015-05-06
MX356072B (es) 2018-05-14
MX2014011122A (es) 2014-12-05
AU2013234931B2 (en) 2017-12-07
RU2666601C2 (ru) 2018-09-11
AU2013234931A2 (en) 2014-12-04
KR102062645B1 (ko) 2020-01-06
AU2013234931A1 (en) 2014-09-18
CN104244985A (zh) 2014-12-24
JP6229188B2 (ja) 2017-11-15
IN2014DN08599A (es) 2015-05-22
PH12014502092A1 (en) 2014-11-24

Similar Documents

Publication Publication Date Title
AR093204A1 (es) Composicion estabilizante para materiales biologicos y metodo de produccion
UA112080C2 (uk) Спосіб одержання водоростевої біомаси і її використання
PH12015502535A1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
IN2015MN00403A (es)
MX2014005574A (es) Material rico en genipina y su uso.
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
LT2009060A (en) Algae spirulina platensis preservation by natural honey
BR112017016441A2 (pt) microcápsula, processo de preparar uma microcápsula, e, produto.
MX2018009819A (es) Soporte nutricional para animales mediante la administracion de un suplemento derivado de algas.
EA201592003A1 (ru) Микропищевые добавки для иммунитета
MX2020009677A (es) Composiciones preparadas de aves de corral y metodos de su uso.
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
AR090108A1 (es) Producto de bicarbonato de sodio
HRP20170372T1 (hr) Prostirka za papkare i njezino recikliranje u kompost
BR112017016445A2 (pt) microcápsula, processo para preparar uma microcápsula, produto, e, comprimido, suplemento dietético ou alimento.
UY37394A (es) Métodos para alterar el contenido de aminoácidos en plantas
ECSP13012702A (es) Productos alimentarios que comprenden grano integral hidrolizado
WO2014120045A3 (en) Method and product (options) of processing chlorella planktonic strain suspension, algolized compound feed-stuff, method of its production, method of introducing the derivative product in a watering system for birds or pigs
CN104171489A (zh) 一种蛋鸡饲料添加剂
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
UA103834C2 (ru) Капсулированный белоксодержащий продукт и способ его получения
BR112015011152A2 (pt) Planta geneticamente modificada, construção genética e método de processamento agrícola ou preparação de alimentação para animais
AR095445A1 (es) Sustancias bioactivas estables y métodos de preparación
AR125129A2 (es) Composición estabilizante para materiales biológicos

Legal Events

Date Code Title Description
FC Refusal